Pruritus
📧 Sign up to get email alerts when something new happens for Pruritus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-01-24FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for hydroxyzine pamoate submitted by Sandoz Inc (ANDA).
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202) [Phase 3]
Phase 3 efficacy and safety results for desloratadine (MK-4117) in Japanese participants with eczema/dermatitis and dermal pruritus have bee…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus
Post-marketing surveillance of Alesion in Japanese pediatric patients with allergic rhinitis, atopic dermatitis (eczema/dermatitis), urticar…
-
FDA approval · 2014-08-20FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved hydroxyzine hydrochloride from Chartwell RX, LLC under an original ANDA (ApplNo=ANDA204279).
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream [Phase 2]
Phase 2 trial evaluating the duration of use experience with Alclometasone Dipropionate Cream has completed with results posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-06-05FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Hydroxyzine Hydrochloride from Teva Pharmaceuticals USA, Inc., granting regulatory clearance…
-
FDA approval · 2014-06-05FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxyzine hydrochloride (Teva Pharmaceuticals USA, Inc.) under ANDA088617, adding a supplement…
-
FDA approval · 2014-06-04FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application for hydroxyzine hydrochloride from KVK-Tech, Inc., indicating updated regulatory authorization for t…
-
FDA approval · 2014-06-04FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for hydroxyzine hydrochloride, authorizing changes to the approved produc…
-
FDA approval · 2014-06-03FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Study of Effectiveness of Mexyn-A [NA]
A clinical trial evaluating Mexyn-A for pruritus has completed; the snippet does not include efficacy results.
-
CLINICAL_TRIALS withdrawal · 2013-08-20Clinical Trial Update: Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children [Phase 1]
This clinical trial update indicates that a Phase 1 study of gabapentin to treat pruritus from burn injuries in children has been withdrawn.
-
FDA approval · 2013-07-22FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for hydroxyzine pamoate submitted by Sandoz Inc. The action relates to a generic product under A…
-
FDA approval · 2013-06-27FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc for hydroxyzine pamoate (ANDA 087479), authorizing the generic product under the app…
-
FDA approval · 2013-06-03FDA Approved: HYDROXYZINE PAMOATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved hydroxyzine pamoate as a generic drug under an Original Application by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuti…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Aprepitant in the Management of Biological Therapies-related Severe Pruritus [Phase 2]
Phase 2 trial evaluating aprepitant for management of severe pruritus related to biological therapies; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults [Phase 2]
This Phase 2 trial of the device RD047-26 for mild to moderate atopic dermatitis in adults has completed, focusing on efficacy and tolerabil…
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: Gabapentin - A Solution to Uremic Pruritus? [NA]
The document reports on a clinical trial evaluating gabapentin for uremic pruritus. The current status is listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus [Phase 2]
A Phase 2 clinical trial evaluating cromolyn sodium for uremic pruritus in patients with end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-29Clinical Trial Update: Evaluation of Post Burn Rehabilitation Population for Itch Control [Phase 4]
Phase 4 clinical trial evaluating itch control in post-burn rehabilitation patients has completed, sponsored by Swiss-American Products, Inc…
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Nalbuphine for the Treatment of Opioid Induced Pruritus in Children [Phase 3]
Phase 3 clinical trial evaluating nalbuphine for opioid-induced pruritus in children has completed, as noted in this update.
-
FDA approval · 2008-09-24FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's hydroxyzine hydrochloride as a generic drug under ANDA 040808.
-
FDA label_change · 2008-08-05FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Hydroxyzine Hydrochloride (Teva Pharmaceuticals USA, Inc.), updating the labeling.
-
FDA approval · 2008-05-29FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' hydroxyzine hydrochloride under an original ANDA; generic entry approved for its existing indications.
-
FDA approval · 2008-03-31FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Northstar RxLLC)
FDA approved Northstar RxLLC's Original Application for hydroxyzine hydrochloride, a generic antihistamine product.